▶ 調査レポート

B型肝炎ウイルス(HBV)の世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Hepatitis B Vir (HBV) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。B型肝炎ウイルス(HBV)の世界市場2020年:企業別、地域別、種類・用途別 / Global Hepatitis B Vir (HBV) Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / D0GIR-01736資料のイメージです。• レポートコード:D0GIR-01736
• 出版社/出版日:GlobalInfoResearch / 2020年9月23日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、B型肝炎ウイルス(HBV)の世界市場を広く調査・分析し、今後の市場展望をまとめております。B型肝炎ウイルス(HBV)の種類別市場規模(治療薬、ワクチン)、用途別市場規模(病院、外来手術センター、診断センター)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Merck、GlaxoSmithKline、Gilead Sciences、Bristol-Myers Squibb、Novartis、La Roche、Hoffmann
・地域別グローバル市場分析 2015年-2020年
・B型肝炎ウイルス(HBV)の北米市場(アメリカ、カナダ、メキシコ)
・B型肝炎ウイルス(HBV)のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・B型肝炎ウイルス(HBV)のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・B型肝炎ウイルス(HBV)の南米市場(ブラジル、アルゼンチン)
・B型肝炎ウイルス(HBV)の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:治療薬、ワクチン
・用途別分析:病院、外来手術センター、診断センター
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Hepatitis B Vir (HBV) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Hepatitis B Vir (HBV) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Hepatitis B Vir (HBV) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Hepatitis B Vir (HBV) market has been segmented into:
Therapeutics
Vaccine

By Application, Hepatitis B Vir (HBV) has been segmented into:
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Hepatitis B Vir (HBV) market presented in the report. This section sheds light on the sales growth of different regional and country-level Hepatitis B Vir (HBV) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Hepatitis B Vir (HBV) market.

The report offers in-depth assessment of the growth and other aspects of the Hepatitis B Vir (HBV) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Hepatitis B Vir (HBV) Market Share Analysis
Hepatitis B Vir (HBV) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Hepatitis B Vir (HBV) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Hepatitis B Vir (HBV) sales, revenue and market share for each player covered in this report.

The major players covered in Hepatitis B Vir (HBV) are:
Merck
GlaxoSmithKline
Gilead Sciences
Bristol-Myers Squibb
Novartis
La Roche
Hoffmann

レポート目次

Table of Contents

1 Hepatitis B Vir (HBV) Market Overview
1.1 Product Overview and Scope of Hepatitis B Vir (HBV)
1.2 Classification of Hepatitis B Vir (HBV) by Type
1.2.1 Global Hepatitis B Vir (HBV) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Hepatitis B Vir (HBV) Revenue Market Share by Type in 2019
1.2.3 Therapeutics
1.2.4 Vaccine
1.3 Global Hepatitis B Vir (HBV) Market by Application
1.3.1 Overview: Global Hepatitis B Vir (HBV) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.4 Global Hepatitis B Vir (HBV) Market by Regions
1.4.1 Global Hepatitis B Vir (HBV) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Hepatitis B Vir (HBV) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Hepatitis B Vir (HBV) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Hepatitis B Vir (HBV) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Hepatitis B Vir (HBV) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Hepatitis B Vir (HBV) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Hepatitis B Vir (HBV) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Merck SWOT Analysis
2.1.4 Merck Product and Services
2.1.5 Merck Hepatitis B Vir (HBV) Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline SWOT Analysis
2.2.4 GlaxoSmithKline Product and Services
2.2.5 GlaxoSmithKline Hepatitis B Vir (HBV) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Gilead Sciences
2.3.1 Gilead Sciences Details
2.3.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Gilead Sciences SWOT Analysis
2.3.4 Gilead Sciences Product and Services
2.3.5 Gilead Sciences Hepatitis B Vir (HBV) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol-Myers Squibb SWOT Analysis
2.4.4 Bristol-Myers Squibb Product and Services
2.4.5 Bristol-Myers Squibb Hepatitis B Vir (HBV) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Hepatitis B Vir (HBV) Revenue, Gross Margin and Market Share (2018-2019)
2.6 La Roche
2.6.1 La Roche Details
2.6.2 La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 La Roche SWOT Analysis
2.6.4 La Roche Product and Services
2.6.5 La Roche Hepatitis B Vir (HBV) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Hoffmann
2.7.1 Hoffmann Details
2.7.2 Hoffmann Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Hoffmann SWOT Analysis
2.7.4 Hoffmann Product and Services
2.7.5 Hoffmann Hepatitis B Vir (HBV) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Hepatitis B Vir (HBV) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Hepatitis B Vir (HBV) Players Market Share
3.2.2 Top 10 Hepatitis B Vir (HBV) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Hepatitis B Vir (HBV) Revenue and Market Share by Regions
4.2 North America Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
4.3 Europe Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
4.5 South America Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
5 North America Hepatitis B Vir (HBV) Revenue by Countries
5.1 North America Hepatitis B Vir (HBV) Revenue by Countries (2015-2020)
5.2 USA Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
5.3 Canada Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
5.4 Mexico Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
6 Europe Hepatitis B Vir (HBV) Revenue by Countries
6.1 Europe Hepatitis B Vir (HBV) Revenue by Countries (2015-2020)
6.2 Germany Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
6.3 UK Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
6.4 France Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
6.5 Russia Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
6.6 Italy Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Hepatitis B Vir (HBV) Revenue by Countries
7.1 Asia-Pacific Hepatitis B Vir (HBV) Revenue by Countries (2015-2020)
7.2 China Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
7.3 Japan Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
7.4 Korea Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
7.5 India Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
8 South America Hepatitis B Vir (HBV) Revenue by Countries
8.1 South America Hepatitis B Vir (HBV) Revenue by Countries (2015-2020)
8.2 Brazil Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
8.3 Argentina Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Hepatitis B Vir (HBV) by Countries
9.1 Middle East & Africa Hepatitis B Vir (HBV) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
9.3 UAE Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
9.4 Egypt Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
9.5 South Africa Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Hepatitis B Vir (HBV) Revenue and Market Share by Type (2015-2020)
10.2 Global Hepatitis B Vir (HBV) Market Forecast by Type (2019-2024)
10.3 Therapeutics Revenue Growth Rate (2015-2025)
10.4 Vaccine Revenue Growth Rate (2015-2025)
11 Global Hepatitis B Vir (HBV) Market Segment by Application
11.1 Global Hepatitis B Vir (HBV) Revenue Market Share by Application (2015-2020)
11.2 Hepatitis B Vir (HBV) Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Ambulatory Surgical Centers Revenue Growth (2015-2020)
11.5 Diagnostic Centers Revenue Growth (2015-2020)
12 Global Hepatitis B Vir (HBV) Market Size Forecast (2021-2025)
12.1 Global Hepatitis B Vir (HBV) Market Size Forecast (2021-2025)
12.2 Global Hepatitis B Vir (HBV) Market Forecast by Regions (2021-2025)
12.3 North America Hepatitis B Vir (HBV) Revenue Market Forecast (2021-2025)
12.4 Europe Hepatitis B Vir (HBV) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Hepatitis B Vir (HBV) Revenue Market Forecast (2021-2025)
12.6 South America Hepatitis B Vir (HBV) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Hepatitis B Vir (HBV) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Hepatitis B Vir (HBV) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Hepatitis B Vir (HBV) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Hepatitis B Vir (HBV) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Hepatitis B Vir (HBV) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Merck Corporate Information, Location and Competitors
Table 6. Merck Hepatitis B Vir (HBV) Major Business
Table 7. Merck Hepatitis B Vir (HBV) Total Revenue (USD Million) (2017-2018)
Table 8. Merck SWOT Analysis
Table 9. Merck Hepatitis B Vir (HBV) Product and Solutions
Table 10. Merck Hepatitis B Vir (HBV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. GlaxoSmithKline Corporate Information, Location and Competitors
Table 12. GlaxoSmithKline Hepatitis B Vir (HBV) Major Business
Table 13. GlaxoSmithKline Hepatitis B Vir (HBV) Total Revenue (USD Million) (2018-2019)
Table 14. GlaxoSmithKline SWOT Analysis
Table 15. GlaxoSmithKline Hepatitis B Vir (HBV) Product and Solutions
Table 16. GlaxoSmithKline Hepatitis B Vir (HBV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Gilead Sciences Corporate Information, Location and Competitors
Table 18. Gilead Sciences Hepatitis B Vir (HBV) Major Business
Table 19. Gilead Sciences Hepatitis B Vir (HBV) Total Revenue (USD Million) (2017-2018)
Table 20. Gilead Sciences SWOT Analysis
Table 21. Gilead Sciences Hepatitis B Vir (HBV) Product and Solutions
Table 22. Gilead Sciences Hepatitis B Vir (HBV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bristol-Myers Squibb Corporate Information, Location and Competitors
Table 24. Bristol-Myers Squibb Hepatitis B Vir (HBV) Major Business
Table 25. Bristol-Myers Squibb Hepatitis B Vir (HBV) Total Revenue (USD Million) (2017-2018)
Table 26. Bristol-Myers Squibb SWOT Analysis
Table 27. Bristol-Myers Squibb Hepatitis B Vir (HBV) Product and Solutions
Table 28. Bristol-Myers Squibb Hepatitis B Vir (HBV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novartis Corporate Information, Location and Competitors
Table 30. Novartis Hepatitis B Vir (HBV) Major Business
Table 31. Novartis Hepatitis B Vir (HBV) Total Revenue (USD Million) (2017-2018)
Table 32. Novartis SWOT Analysis
Table 33. Novartis Hepatitis B Vir (HBV) Product and Solutions
Table 34. Novartis Hepatitis B Vir (HBV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. La Roche Corporate Information, Location and Competitors
Table 36. La Roche Hepatitis B Vir (HBV) Major Business
Table 37. La Roche Hepatitis B Vir (HBV) Total Revenue (USD Million) (2017-2018)
Table 38. La Roche SWOT Analysis
Table 39. La Roche Hepatitis B Vir (HBV) Product and Solutions
Table 40. La Roche Hepatitis B Vir (HBV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Hoffmann Corporate Information, Location and Competitors
Table 42. Hoffmann Hepatitis B Vir (HBV) Major Business
Table 43. Hoffmann Hepatitis B Vir (HBV) Total Revenue (USD Million) (2017-2018)
Table 44. Hoffmann SWOT Analysis
Table 45. Hoffmann Hepatitis B Vir (HBV) Product and Solutions
Table 46. Hoffmann Hepatitis B Vir (HBV) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Global Hepatitis B Vir (HBV) Revenue (Million USD) by Players (2015-2020)
Table 48. Global Hepatitis B Vir (HBV) Revenue Share by Players (2015-2020)
Table 49. Global Hepatitis B Vir (HBV) Revenue (Million USD) by Regions (2015-2020)
Table 50. Global Hepatitis B Vir (HBV) Revenue Market Share by Regions (2015-2020)
Table 51. North America Hepatitis B Vir (HBV) Revenue by Countries (2015-2020)
Table 52. North America Hepatitis B Vir (HBV) Revenue Market Share by Countries (2015-2020)
Table 53. Europe Hepatitis B Vir (HBV) Revenue (Million USD) by Countries (2015-2020)
Table 54. Asia-Pacific Hepatitis B Vir (HBV) Revenue (Million USD) by Countries (2015-2020)
Table 55. South America Hepatitis B Vir (HBV) Revenue by Countries (2015-2020)
Table 56. South America Hepatitis B Vir (HBV) Revenue Market Share by Countries (2015-2020)
Table 57. Middle East and Africa Hepatitis B Vir (HBV) Revenue (Million USD) by Countries (2015-2020)
Table 58. Middle East and Africa Hepatitis B Vir (HBV) Revenue Market Share by Countries (2015-2020)
Table 59. Global Hepatitis B Vir (HBV) Revenue (Million USD) by Type (2015-2020)
Table 60. Global Hepatitis B Vir (HBV) Revenue Share by Type (2015-2020)
Table 61. Global Hepatitis B Vir (HBV) Revenue Forecast by Type (2021-2025)
Table 62. Global Hepatitis B Vir (HBV) Revenue by Application (2015-2020)
Table 63. Global Hepatitis B Vir (HBV) Revenue Share by Application (2015-2020)
Table 64. Global Hepatitis B Vir (HBV) Revenue Forecast by Application (2021-2025)
Table 65. Global Hepatitis B Vir (HBV) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Hepatitis B Vir (HBV) Picture
Figure 2. Global Hepatitis B Vir (HBV) Revenue Market Share by Type in 2019
Figure 3. Therapeutics Picture
Figure 4. Vaccine Picture
Figure 5. Hepatitis B Vir (HBV) Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Ambulatory Surgical Centers Picture
Figure 8. Diagnostic Centers Picture
Figure 9. Global Hepatitis B Vir (HBV) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Hepatitis B Vir (HBV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Hepatitis B Vir (HBV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Hepatitis B Vir (HBV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Hepatitis B Vir (HBV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Hepatitis B Vir (HBV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Hepatitis B Vir (HBV) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Hepatitis B Vir (HBV) Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Hepatitis B Vir (HBV) Revenue Market Share in 2019
Figure 18. Global Top 10 Players Hepatitis B Vir (HBV) Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Hepatitis B Vir (HBV) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Hepatitis B Vir (HBV) Revenue Market Share by Regions (2015-2020)
Figure 22. Global Hepatitis B Vir (HBV) Revenue Market Share by Regions in 2018
Figure 23. North America Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 24. Europe Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 26. South America Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 28. North America Hepatitis B Vir (HBV) Revenue Market Share by Countries (2015-2020)
Figure 29. North America Hepatitis B Vir (HBV) Revenue Market Share by Countries in 2019
Figure 30. USA Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 31. Canada Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 33. Europe Hepatitis B Vir (HBV) Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Hepatitis B Vir (HBV) Revenue Market Share by Countries in 2019
Figure 35. Germany Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 36. UK Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 37. France Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 38. Russia Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 39. Italy Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Hepatitis B Vir (HBV) Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Hepatitis B Vir (HBV) Revenue Market Share by Countries in 2019
Figure 42. China Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 43. Japan Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 44. Korea Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 45. India Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 47. South America Hepatitis B Vir (HBV) Revenue Market Share by Countries (2015-2020)
Figure 48. South America Hepatitis B Vir (HBV) Revenue Market Share by Countries in 2019
Figure 49. Brazil Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Hepatitis B Vir (HBV) Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Hepatitis B Vir (HBV) Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 54. UAE Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Hepatitis B Vir (HBV) Revenue and Growth Rate (2015-2020)
Figure 57. Global Hepatitis B Vir (HBV) Revenue Share by Type (2015-2020)
Figure 58. Global Hepatitis B Vir (HBV) Revenue Share by Type in 2019
Figure 59. Global Hepatitis B Vir (HBV) Market Share Forecast by Type (2021-2025)
Figure 60. Global Therapeutics Revenue Growth Rate (2015-2020)
Figure 61. Global Vaccine Revenue Growth Rate (2015-2020)
Figure 62. Global Hepatitis B Vir (HBV) Revenue Share by Application (2015-2020)
Figure 63. Global Hepatitis B Vir (HBV) Revenue Share by Application in 2019
Figure 64. Global Hepatitis B Vir (HBV) Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Ambulatory Surgical Centers Revenue Growth Rate (2015-2020)
Figure 67. Global Diagnostic Centers Revenue Growth Rate (2015-2020)
Figure 68. Global Hepatitis B Vir (HBV) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Hepatitis B Vir (HBV) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Hepatitis B Vir (HBV) Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Hepatitis B Vir (HBV) Revenue Market Forecast (2021-2025)
Figure 72. Europe Hepatitis B Vir (HBV) Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Hepatitis B Vir (HBV) Revenue Market Forecast (2021-2025)
Figure 74. South America Hepatitis B Vir (HBV) Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Hepatitis B Vir (HBV) Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel